2003•Unpublished venueRequires access

Enhanced cytotoxicity of dimethylformamide by ultrasound in vitro

Russell J. Jeffers, Ruo Qin Feng, J. Brian Fowlkes, JOHN W. HUNT, Charles A. Cain

Open publisher page 3 citations

Abstract

Polar solvents, including dimethylformamide (DMF), are investigated as anticancer drugs. The effects of a noncytotoxic DMF dose alone and with ultrasound exposure on HL-60 human promyelocytic leukemia cells grown in suspension culture are examined. The cells are insonified in a free field configuration which creates little cytotoxicity without the introduction of albumin stabilized microbubbles into the exposure chamber. When microbubbles are introduced, cytotoxicity of DMF and ultrasound is significantly higher than for ultrasound alone. The necessary presence of microbubbles for the enhanced cytotoxicity of DMF by ultrasound suggests that a likely enhancement mechanism is acoustic cavitation which should be initiated by the existence of microbubbles as nuclei. Albumin stabilized microbubbles, similar to those presently used as ultrasound contrast agents, may provide a significant source of nuclei and improve prospects for cancer therapy using acoustic cavitation.>

About this research paper

What this paper is about

Polar solvents, including dimethylformamide (DMF), are investigated as anticancer drugs. The effects of a noncytotoxic DMF dose alone and with ultrasound exposure on HL-60 human promyelocytic leukemia cells grown in suspension culture are examined. The cells are insonified in a free field configuration which creates little cytotoxicity without the introduction of albumin stabilized microbubbles into the exposure chamber. When microbubbles are introduced, cytotoxicity of DMF and ultrasound is significantly higher than for ultrasound alone. The necessary presence of microbubbles for the enhanced cytotoxicity of DMF by ultrasound suggests that a likely enhancement mechanism is acoustic cavitation which should be initiated by the existence of microbubbles as nuclei. Albumin stabilized microbubbles, similar to those presently used as ultrasound contrast agents, may provide a significant source of nuclei and improve prospects for cancer therapy using acoustic cavitation.>

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Polar solvents, including dimethylformamide (DMF), are investigated as anticancer drugs. The effects of a noncytotoxic DMF dose alone and with ultrasound exposure on HL-60 human promyelocytic leukemia cells grown in suspension culture are examined. The cells are insonified in a free field configuration which creates little cytotoxicity without the introduction of albumin stabilized microbubbles into the exposure chamber. When microbubbles are introduced, cytotoxicity of DMF and ultrasound is significantly higher than for ultrasound alone. The necessary presence of microbubbles for the enhanced cytotoxicity of DMF by ultrasound suggests that a likely enhancement mechanism is acoustic cavitation which should be initiated by the existence of microbubbles as nuclei. Albumin stabilized microbubbles, similar to those presently used as ultrasound contrast agents, may provide a significant source of nuclei and improve prospects for cancer therapy using acoustic cavitation.>

Key concepts: Microbubbles, Cytotoxicity, Ultrasound, Cavitation, Chemistry, In vitro, Dimethylformamide, Albumin

Related papers

Back to paper searchBrowse research topicsOriginal source
Enhanced cytotoxicity of dimethylformamide by ultrasound in vitro — Research Paper | ScholarLens